0
     

Report Added
Report already added
Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027

Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027

MarketsandMarkets expects the soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically advanced products, and increasing volume of surgeries and growing prevalence of severe trauma injuries.

This, in turn, unfavorable reimbursement scenario and high price of soft tissue repair products and the rising cost of surgical procedures are the key factors restraining the growth of the market. In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.

In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.

“Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by product type”

Based on product, soft tissue repair market is segmented into tissue patch/mash and laproscopicintrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.

“Hernia Repair accounted for the largest share in the soft tissue repair market by Application”

Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.

“Hospital segment accounted for the largest share in the soft tissue repair market by End User”

Based on end users, the soft tissue repair market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.

“North America segment accounted for the largest share in the soft tissue repair market by Region”

On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.

Key Market Players :
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.

A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
•By Company Type: Tier 1–5%, Tier 2–15%, and Tier 3–80%
•By Designation: C-level–45%, Director Level–25%, and Others–30%
•By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%

Research Coverage:
The market study covers the soft tissue repair market across various segments. It aims at estimating the market sizeand the growth potential of this market across different segmentsby product, by application, by end user, and by region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repairmarket and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Table of Contents

1INTRODUCTION29
1.1OBJECTIVES OF THE STUDY29
1.2MARKET DEFINITION29
1.2.1INCLUSIONS AND EXCLUSIONS29
1.3MARKET SCOPE30
1.3.1MARKETS COVERED30
1.3.2MARKETS COVERED – BY REGION30
1.3.3YEARS CONSIDERED FOR THE STUDY31
1.4CURRENCY31
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD31
1.5STAKEHOLDERS32
1.6SUMMARY OF CHANGES32
2RESEARCH METHODOLOGY34
2.1RESEARCH APPROACH34
FIGURE 1RESEARCH DESIGN34
2.1.1SECONDARY DATA34
2.1.1.1Key data from secondary sources35
2.1.2PRIMARY DATA36
2.1.2.1Primary sources36
2.1.2.2Key data from primary sources37
2.1.2.3Breakdown of primaries37
FIGURE 2BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION37
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION38
2.2MARKET SIZE ESTIMATION38
FIGURE 4MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)39
FIGURE 5SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET40
FIGURE 6TOP-DOWN APPROACH41
FIGURE 7CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOFT TISSUE REPAIR MARKET (2022–2027)42
2.3GROWTH FORECAST42
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE
REPAIR MARKET (2021)43
2.4MARKET BREAKDOWN & DATA TRIANGULATION44
FIGURE 9DATA TRIANGULATION METHODOLOGY44
2.5KEY INDUSTRY INSIGHTS45

2.6LIMITATIONS45
2.6.1METHODOLOGY-RELATED LIMITATIONS45
2.7RISK ASSESSMENT46
2.8ASSUMPTIONS FOR THE STUDY46
3EXECUTIVE SUMMARY47
FIGURE 10SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)47
FIGURE 11SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)48
FIGURE 12SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)48
FIGURE 13GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET49
4PREMIUM INSIGHTS50
4.1SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW50
FIGURE 14INCREASING HERNIA CASES AND TRAUMA INJURIES AND
GROWING R&D DRIVE THE MARKET50
4.2REGIONAL MIX: SOFT TISSUE REPAIR MARKET50
FIGURE 15APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD50
4.3ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2021)51
FIGURE 16TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE
OF THE ASIA PACIFIC MARKET IN 202151
4.4SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES52
FIGURE 17CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD52
4.5SOFT TISSUE REPAIR MARKET: DEVELOPED VS. DEVELOPING MARKETS52
FIGURE 18DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE
DURING THE FORECAST PERIOD52
5MARKET OVERVIEW53
5.1INTRODUCTION53
5.2MARKET DYNAMICS: IMPACT ANALYSIS53
5.2.1DRIVERS54
5.2.1.1Increasing aging population and obesity rate54
5.2.1.2Growing incidence of sports injuries54
5.2.1.3Strong focus on R&D55
5.2.1.4Increasing volume of surgeries and growing prevalence of
severe trauma injuries55
TABLE 2UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL
PROCEDURES PERFORMED56
5.2.2RESTRAINTS57
5.2.2.1Unfavorable reimbursement scenario57
5.2.2.2High product and procedure costs57
5.2.3OPPORTUNITIES58
5.2.3.1Growing adoption of advanced soft tissue repair products in emerging markets58
TABLE 3COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)58
5.2.3.2Growing use of combination materials for enhancing product efficacy59
5.2.4CHALLENGES59
5.2.4.1Stringent regulatory framework59
5.2.4.2Need for skilled personnel60
5.3ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN
SOFT TISSUE REPAIR MARKET60
5.4ECOSYSTEM ANALYSIS61
FIGURE 19SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS61
5.5PRICING ANALYSIS62
TABLE 4AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS62
5.6SUPPLY CHAIN ANALYSIS62
FIGURE 20SUPPLY CHAIN ANALYSIS: SOFT TISSUE REPAIR MARKET (2021)62
5.7PATENT ANALYSIS64
5.7.1PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET64
FIGURE 21GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–202164
5.7.2TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS65
FIGURE 22TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–202165
5.7.3JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE SOFT TISSUE REPAIR MARKET65
FIGURE 23JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–202165
5.8VALUE CHAIN ANALYSIS66
FIGURE 24SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021)66
5.9TECHNOLOGY ANALYSIS67
5.10KEY CONFERENCES & EVENTS IN 2022–202367
5.11REGULATORY LANDSCAPE68
TABLE 5REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE
REPAIR PRODUCTS, BY COUNTRY/REGION68
5.12PORTER’S FIVE FORCES ANALYSIS68
TABLE 6SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS68
5.12.1THREAT FROM NEW ENTRANTS69
5.12.2COMPETITIVE RIVALRY69
5.12.3BARGAINING POWER OF BUYERS69
5.12.4BARGAINING POWER OF SUPPLIERS70
5.12.5THREAT FROM SUBSTITUTES70
5.13KEY STAKEHOLDERS & BUYING CRITERIA70
5.13.1KEY STAKEHOLDERS IN BUYING PROCESS70
FIGURE 25INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS70
TABLE 7INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS (%)71

5.13.2BUYING CRITERIA71
FIGURE 26KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS71
TABLE 8KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS72
6SOFT TISSUE REPAIR MARKET, BY PRODUCT73
6.1INTRODUCTION74
TABLE 9SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)74
6.2TISSUE PATCHES/MESHES74
TABLE 10SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION)75
TABLE 11SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)75
6.2.1SYNTHETIC MESHES76
6.2.1.1Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness76
TABLE 12SOFT TISSUE REPAIR MARKET FOR SYNTHETIC MESHES, BY COUNTRY,
2020–2027 (USD MILLION)76
6.2.2BIOLOGICAL MESHES77
TABLE 13SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION)77
TABLE 14SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE,
2020–2027 (USD MILLION)78
6.2.2.1Allografts78
6.2.2.1.1Biocompatibility and superior aesthetic results drive the use of allografts78
TABLE 15SOFT TISSUE REPAIR MARKET FOR ALLOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION)79
6.2.2.2Xenografts79
6.2.2.2.1Xenografts are more viable than allografts due to availability and size ranges79
TABLE 16SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY,
2020–2027 (USD MILLION)80
6.2.3FIXATION PRODUCTS80
TABLE 17SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)81
TABLE 18SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)81
6.2.3.1Suture anchors82
6.2.3.1.1Growing injury incidence and need for surgery drive demand for suture anchors82
TABLE 19SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY,
2020–2027 (USD MILLION)82
6.2.3.2Interference screws83
6.2.3.2.1Availability of advanced biodegradable screws and development of biocomposites drives the market growth83
TABLE 20SOFT TISSUE REPAIR MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION)83
6.2.3.3Other fixation products83
TABLE 21SOFT TISSUE REPAIR MARKET FOR OTHER FIXATION PRODUCTS,
BY COUNTRY, 2020–2027 (USD MILLION)84
6.3LAPAROSCOPIC INSTRUMENTS84
6.3.1QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS84
TABLE 22SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS,
BY COUNTRY, 2020–2027 (USD MILLION)85
7SOFT TISSUE REPAIR MARKET, BY APPLICATION86
7.1INTRODUCTION87
TABLE 23SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)87
7.2HERNIA REPAIR87
7.2.1HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFT TISSUE REPAIR MARKET87
TABLE 24SOFT TISSUE REPAIR MARKET FOR HERNIA REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)88
7.3SKIN REPAIR88
7.3.1INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET88
TABLE 25SOFT TISSUE REPAIR MARKET FOR SKIN REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)89
7.4ORTHOPEDIC REPAIR89
7.4.1INCREASING NUMBER OF SPORTS INJURIES DRIVES
ORTHOPEDIC REPAIR MARKET89
TABLE 26SOFT TISSUE REPAIR MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)90
7.5DENTAL REPAIR90
7.5.1RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET90
TABLE 27SOFT TISSUE REPAIR MARKET FOR DENTAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)91
7.6BREAST RECONSTRUCTION91
7.6.1RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH91
TABLE 28SOFT TISSUE REPAIR MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION)92
7.7DURAL REPAIR92
7.7.1RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL SOFT TISSUE REPAIR MARKET92
TABLE 29SOFT TISSUE REPAIR MARKET FOR DURAL REPAIR, BY COUNTRY,
2020–2027 (USD MILLION)93
7.8VAGINAL SLING PROCEDURES93
7.8.1DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN93
TABLE 30SOFT TISSUE REPAIR MARKET FOR VAGINAL SLING PROCEDURES,
BY COUNTRY, 2020–2027 (USD MILLION)94

7.9OTHER APPLICATIONS94
TABLE 31SOFT TISSUE REPAIR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)95
8SOFT TISSUE REPAIR MARKET, BY END USER96
8.1INTRODUCTION97
TABLE 32SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)97
8.2HOSPITALS97
8.2.1HOSPITALS ARE THE LARGEST END USERS OF
SOFT TISSUE REPAIR PRODUCTS97
TABLE 33SOFT TISSUE REPAIR MARKET FOR HOSPITALS, BY COUNTRY,
2020–2027 (USD MILLION)98
8.3CLINICS98
8.3.1QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS98
TABLE 34SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY,
2020–2027(USD MILLION)99
8.4OTHER END USERS99
TABLE 35SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY,
2020–2027 (USD MILLION)100
9SOFT TISSUE REPAIR MARKET, BY REGION101
9.1INTRODUCTION102
FIGURE 27INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE
SOFT TISSUE REPAIR MARKET102
TABLE 36SOFT TISSUE REPAIR MARKET, BY REGION, 2020–2027 (USD MILLION)102
9.2NORTH AMERICA103
FIGURE 28NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT104
TABLE 37NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)104
TABLE 38NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)105
TABLE 39NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 40NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 41NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)106
TABLE 42NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)106
TABLE 43NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)107
9.2.1US107
9.2.1.1Presence of prominent market players and high per capita income supports market growth in the US107
TABLE 44US: MACROECONOMIC INDICATORS107
TABLE 45US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)108
TABLE 46US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 47US: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 48US: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)109
TABLE 49US: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)109
TABLE 50US: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)109
9.2.2CANADA110
9.2.2.1Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth110
TABLE 51CANADA: MACROECONOMIC INDICATORS110
TABLE 52CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)110
TABLE 53CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)111
TABLE 54CANADA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 55CANADA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 56CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)112
TABLE 57CANADA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)112
9.3EUROPE112
FIGURE 29EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT113
TABLE 58EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)114
TABLE 59EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)114
TABLE 60EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)114
TABLE 61EUROPE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)115
TABLE 62EUROPE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)115
TABLE 63EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)115
TABLE 64EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)116
9.3.1GERMANY116
9.3.1.1Germany holds the largest share of the European market116
TABLE 65GERMANY: MACROECONOMIC INDICATORS116
TABLE 66GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)117
TABLE 67GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)117
TABLE 68GERMANY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES,
BY TYPE, 2020–2027 (USD MILLION)117
TABLE 69GERMANY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)118
TABLE 70GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)118
TABLE 71GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)118
9.3.2FRANCE119
9.3.2.1Presence of a well-established healthcare system and growing geriatric population to boost the market growth119
TABLE 72FRANCE: MACROECONOMIC INDICATORS119
TABLE 73FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)119
TABLE 74FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)120
TABLE 75FRANCE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 76FRANCE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 77FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)121
TABLE 78FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)121
9.3.3UK121
9.3.3.1Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth121
TABLE 79UK: MACROECONOMIC INDICATORS122
TABLE 80UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 81UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)122
TABLE 82UK: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)123
TABLE 83UK: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE,
2020–2027 (USD MILLION)123
TABLE 84UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)123
TABLE 85UK: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)124
9.3.4ITALY124
9.3.4.1Increasing volume of surgeries to drive the demand for soft tissue repair products in the country124
TABLE 86ITALY: MACROECONOMIC INDICATORS124
TABLE 87ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)125
TABLE 88ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)125
TABLE 89ITALY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 90ITALY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 91ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)126
TABLE 92ITALY: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)126
9.3.5SPAIN127
9.3.5.1Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth127
TABLE 93SPAIN: MACROECONOMIC INDICATORS127
TABLE 94SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)128
TABLE 95SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)128
TABLE 96SPAIN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 97SPAIN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)129
TABLE 98SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)129
TABLE 99SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)129
9.3.6REST OF EUROPE130
TABLE 100ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)130
TABLE 101ROE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 102ROE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 103ROE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 104ROE: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)132
TABLE 105ROE: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)132
9.4ASIA PACIFIC132
FIGURE 30ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT133
TABLE 106APAC: SOFT TISSUE REPAIR MARKET, BY COUNTRY,
2020–2027 (USD MILLION)134
TABLE 107APAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)134
TABLE 108APAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)134
TABLE 109APAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 110APAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 111APAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)135
TABLE 112APAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)136
9.4.1JAPAN136
9.4.1.1Strong healthcare system and rising geriatric population to support market growth in Japan136
TABLE 113JAPAN: MACROECONOMIC INDICATORS137
TABLE 114JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)137
TABLE 115JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)137
TABLE 116JAPAN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 117JAPAN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 118JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)138
TABLE 119JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)139
9.4.2CHINA139
9.4.2.1Growing number of hospitals and healthcare policy reforms stimulating market growth139
TABLE 120CHINA: MACROECONOMIC INDICATORS140
TABLE 121CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)140
TABLE 122CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)140
TABLE 123CHINA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 124CHINA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)141
TABLE 125CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)141
TABLE 126CHINA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)142
9.4.3INDIA142
9.4.3.1Rising healthcare awareness and favorable government support to stimulate market growth in India142
TABLE 127INDIA: MACROECONOMIC INDICATORS143
TABLE 128INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)143
TABLE 129INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)143
TABLE 130INDIA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 131INDIA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 132INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)144
TABLE 133INDIA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)145
9.4.4REST OF ASIA PACIFIC145
TABLE 134ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)145
TABLE 135ROAPAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)146
TABLE 136ROAPAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 137ROAPAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 138ROAPAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)147
TABLE 139ROAPAC: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)147
9.5LATIN AMERICA147
9.5.1LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA147
TABLE 140LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)148
TABLE 141LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 142LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 143LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS,
BY TYPE, 2020–2027 (USD MILLION)149
TABLE 144LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)149
TABLE 145LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)150
9.6MIDDLE EAST & AFRICA150
9.6.1MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS150
TABLE 146MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT,
2020–2027 (USD MILLION)151
TABLE 147MEA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES,
BY TYPE, 2020–2027 (USD MILLION)151
TABLE 148MEA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 149MEA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 150MEA: SOFT TISSUE REPAIR MARKET, BY APPLICATION,
2020–2027 (USD MILLION)152
TABLE 151MEA: SOFT TISSUE REPAIR MARKET, BY END USER,
2020–2027 (USD MILLION)152

10COMPETITIVE LANDSCAPE153
10.1OVERVIEW153
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN153
10.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS154
FIGURE 31REVENUE ANALYSIS OF THE TOP PLAYERS IN THE
SOFT TISSUE REPAIR MARKET154
10.4MARKET SHARE ANALYSIS155
FIGURE 32SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020155
10.5COMPANY EVALUATION QUADRANT156
10.5.1STARS156
10.5.2PERVASIVE PLAYERS156
10.5.3EMERGING LEADERS157
10.5.4PARTICIPANTS157
FIGURE 33SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021157
10.6COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS158
10.6.1PROGRESSIVE COMPANIES158
10.6.2DYNAMIC COMPANIES158
10.6.3STARTING BLOCKS158
10.6.4RESPONSIVE COMPANIES158
FIGURE 34SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
FOR SMES & START-UP159
10.7COMPETITIVE BENCHMARKING160
10.7.1OVERALL COMPANY FOOTPRINT160
TABLE 152OVERALL COMPANY FOOTPRINT (25 COMPANIES)160
TABLE 153COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)161
TABLE 154COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)162
TABLE 155COMPANY FOOTPRINT: BY REGION (25 COMPANIES)163
10.8COMPETITIVE SCENARIO165
10.8.1DEALS165
TABLE 156DEALS165
10.8.2OTHER DEVELOPMENTS166
TABLE 157OTHER DEVELOPMENTS166
11COMPANY PROFILES167
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1KEY PLAYERS167
11.1.1ARTHREX INC.167
TABLE 158ARTHREX INC.: BUSINESS OVERVIEW167
11.1.2SMITH & NEPHEW PLC169
TABLE 159SMITH & NEPHEW PLC: BUSINESS OVERVIEW169
FIGURE 35SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)170
11.1.3JOHNSON & JOHNSON173
TABLE 160JOHNSON & JOHNSON: BUSINESS OVERVIEW173
FIGURE 36JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)174
11.1.4BECTON, DICKINSON & COMPANY177
TABLE 161BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW177
FIGURE 37BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)177
11.1.5STRYKER CORPORATION181
TABLE 162STRYKER CORPORATION: BUSINESS OVERVIEW181
FIGURE 38STRYKER CORPORATION: COMPANY SNAPSHOT (2020)182
11.1.6MEDTRONIC PLC.184
TABLE 163MEDTRONIC PLC.: BUSINESS OVERVIEW184
FIGURE 39MEDTRONIC PLC.: COMPANY SNAPSHOT (2020)185
11.1.7ZIMMER BIOMET188
TABLE 164ZIMMER BIOMET: BUSINESS OVERVIEW188
FIGURE 40ZIMMER BIOMET: COMPANY SNAPSHOT (2020)189
11.1.8INTEGRA LIFESCIENCES HOLDINGS CORPORATION191
TABLE 165INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW191
FIGURE 41INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020)192
11.1.9CRYOLIFE INC.194
TABLE 166CRYOLIFE INC.: BUSINESS OVERVIEW194
FIGURE 42CRYOLIFE INC.: COMPANY SNAPSHOT (2020)195
11.1.10ORGANOGENESIS INC.197
TABLE 167ORGANOGENESIS INC.: BUSINESS OVERVIEW197
FIGURE 43ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)197
11.2OTHER PLAYERS199
11.2.1LIFENET HEALTH INC.199
TABLE 168LIFENET HEALTH INC.: BUSINESS OVERVIEW199
11.2.2BAXTER INTERNATIONAL, INC.201
TABLE 169BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW201
FIGURE 44BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020)202
11.2.3TISSUE REGENIX GROUP PLC204
TABLE 170TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW204
FIGURE 45TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)204
11.2.4CONMED CORPORATION207
TABLE 171CONMED CORPORATION: BUSINESS OVERVIEW207
FIGURE 46CONMED CORPORATION: COMPANY SNAPSHOT (2020)208
11.2.5MERIL LIFE SCIENCES PVT. LTD.210
TABLE 172MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW210
11.2.6RTI SURGICAL211
TABLE 173RTI SURGICAL: BUSINESS OVERVIEW211
11.2.7SAMYANG HOLDINGS CORPORATION212
TABLE 174SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW212
11.2.8AROA BIOSURGERY LTD.213
TABLE 175AROA BIOSURGERY LTD.: BUSINESS OVERVIEW213
11.2.9ACERA SURGICAL INC.214
TABLE 176ACERA SURGICAL INC.: BUSINESS OVERVIEW214
11.2.10ORTHOCELL LTD.215
TABLE 177ORTHOCELL LTD.: BUSINESS OVERVIEW215
11.2.11ACELL INC.216
TABLE 178ACELL INC.: BUSINESS OVERVIEW216
11.2.12BIOCER ENTWICKLUNGS-GMBH217
TABLE 179BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW217
11.2.13ISTO BIOLOGICS218
TABLE 180ISTO BIOLOGICS: BUSINESS OVERVIEW218
11.2.14BETATECH MEDICAL219
TABLE 181BETATECH MEDICAL: BUSINESS OVERVIEW219
11.2.15MIMEDX220
TABLE 182MIMEDX: BUSINESS OVERVIEW220
FIGURE 47MIMEDX: COMPANY SNAPSHOT (2020)220
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12APPENDIX222
12.1INDUSTRY INSIGHTS222
12.2DISCUSSION GUIDE223
12.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL226
12.4AVAILABLE CUSTOMIZATIONS228
12.5RELATED REPORTS228
12.6AUTHOR DETAILS229

Report Title: Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW